Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 5
Submit an article Journal homepage
261
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Outcomes of second-line treatment in chronic lymphocytic leukemia – a population-based study from a well defined geographical region between 2003 and 2013

Anna AsklidDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; ;Department of Oncology, Karolinska University Hospital, Stockholm, Sweden;
,
Maria WinqvistDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; ;Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden;
,
Sandra Eketorp SylvanDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;
,
Agnes MattssonDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; ;Department of Internal Medicine, Södersjukhuset, Stockholm, Sweden;
,
Einar BjörgvinssonDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; ;Department of Oncology, Karolinska University Hospital, Stockholm, Sweden;
,
Frans SøltoftJanssen Nordic, Birkerød, Denmark;
,
Johanna RepitsPreviously at Janssen Nordic, Stockholm, Sweden;
,
Joris DielsJanssen EMEA, Antwerp, Belgium
,
Anders ÖsterborgDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; ;Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden;
&
Lotta HanssonDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; ;Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden; Correspondence[email protected]
 show all
Pages 1219-1223 | Received 10 Jun 2016, Accepted 03 Oct 2016, Published online: 28 Nov 2016
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Acknowledgements

This study was funded by Janssen-Cilag AB. Additional research funding was provided by the following foundations: The Swedish Cancer Society, The Cancer Society in Stockholm, King Gustav V Jubilee Fund, The Cancer and Allergy Foundation, StratCan Karolinska Institutet, AFA Insurance, The Stockholm County Council, The Swedish Society of Medicine, Blodcancerfonden and Dr Åke Olsson Foundation. We thank Ms Leila Relander for secretarial assistance, Peter Gray, Nicholas Rusbridge of PAREXEL Access Consulting and Dusha Jeyakumaran of Janssen EMEA for editorial support.

Presented in part at the Annual Meeting of the American Society of Hematology, Orlando, FL, Dec 5-8, 2015.

Potential conflict of interest

Anders Österborg and Lotta Hansson have received research grant support and honoraria for scientific lectures from Janssen. Johanna Repits, Frans Søltoft , Joris Diels are previous or present employees at Janssen-Cilag. The other authors declared no conflict of interest. Disclosure forms provided by the authors are available with the full text of this article at http://dx.doi.org/10.1080/10428194.2016.1246727.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.